Ketodotask (Ketoprofen Lysine)

Ketoprofen Lysine acts on inflammatory pathways to relieve pain and swelling in several musculoskeletal disorders.

• Rheumatoid arthritis: reduces joint inflammation and pain, improving function.
• Osteoarthritis: alleviates chronic joint discomfort and stiffness.
• Musculoskeletal pain: eases strain‑related aches in back, limbs and soft tissues.
• Post‑operative pain: provides short‑term relief after surgical procedures.

• Ketoprofen Lysine non‑selectively inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, decreasing the conversion of arachidonic acid to prostaglandins. The reduced prostaglandin synthesis limits inflammation, pain signaling, and fever generation at sites of tissue injury.

Ketodotask may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Gastrointestinal upset: nausea, dyspepsia, abdominal discomfort.
• Headache or dizziness.
• Skin rash or pruritus.
• Mild elevation of liver enzymes.
• Fluid retention or mild edema.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulcer perforation.
• Severe renal impairment or acute kidney injury.
• Anaphylactic or severe hypersensitivity reactions.
• Hepatotoxicity with marked liver enzyme rise.
• Cardiovascular events such as myocardial infarction or stroke.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Ketodotask, clinicians should evaluate patient‑specific risk factors and monitor therapy.

• Assess gastrointestinal risk: avoid in patients with active ulcer disease.
• Monitor renal function: use caution in those with existing kidney impairment.
• Use the lowest effective dose for the shortest duration needed.
• Avoid in individuals with known hypersensitivity to ketoprofen or other NSAIDs.
• Caution in patients with cardiovascular disease or uncontrolled hypertension.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ketodotask can alter the effects of several co‑administered medicines.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or aspirin: heightened gastrointestinal toxicity.
• Corticosteroids: additive ulcer risk.
• Lithium: possible increase in serum lithium levels.
• Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may diminish renal function.
• Diuretics: risk of renal impairment.
• Antihypertensives: possible reduction in blood pressure control.
• Selective serotonin reuptake inhibitors: increased bleeding tendency.
• Oral hypoglycemics: potential alteration of glucose control.